Startups · AI

Research Scientist I/II, Immunology

Iambic Therapeutics · San Diego HQ · On-site

← All jobs
About Iambic Therapeutics

Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need. Backed by Sequoia.

About the role

We are seeking a highly motivated, hands-on Research Scientist I/II with strong immunology training to join the Biology group and support small-molecule drug discovery programs at Iambic Therapeutics. The successful candidate will design and execute in vitro and ex vivo studies that generate high-quality data for target validation, hit-to-lead, lead optimization, and development candidate selection.

More about this role

JOB SUMMARY

We are seeking a highly motivated, hands-on Research Scientist I/II with strong immunology training to join the Biology group and support small-molecule drug discovery programs at Iambic Therapeutics. The successful candidate will design and execute in vitro and ex vivo studies that generate high-quality data for target validation, hit-to-lead, lead optimization, and development candidate selection. The candidate will collaborate closely with colleagues in biology, medicinal chemistry, DMPK, in vivo pharmacology, computational biology, machine learning, and compound management groups. This role is based at our San Diego headquarters.

KEY RESPONSIBILITIES

Design, develop, optimize, troubleshoot, and execute assays using disease-relevant immune cells and tissues, including primary human and/or pre-clinical immune cells, whole blood, cell lines, and tissue-derived systems, to measure potency, selectivity, target engagement, mechanism of action, and functional immune responses.

Run recurring compound-profiling assays and generate timely, reproducible data to support medicinal chemistry design-make-test-analyze cycles from hit-to-lead through lead optimization and...

Read the full posting on Iambic Therapeutics's site ↗

Science

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.